ACAD

ACADIA Pharmaceuticals Inc. News Headlines

$28.43
*  
0.69
2.49%
Get ACAD Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading ACAD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACAD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
ACADIA Pharma. To Present At Jefferies Global Conference; Webcast At 4:20 AM ET
11/20/2014 3:20:00 AM - RTT News


Acadia Pharma Q3 Results Miss View; Pushes Back Nuplazid NDA Submission
11/10/2014 9:36:00 PM - RTT News


ACADIA Pharma Q3 Loss Widens - Quick Facts
11/10/2014 4:19:00 PM - RTT News


After-Hours Earnings Report for November 10, 2014 : RAX, DEI, WWD, PRAA, NPSP, CIB, ACAD, ATW, ATLS, CZR, HK, ARP
11/10/2014 2:00:03 PM - NASDAQ.com News


Cramer's Lightning Round - Wait To Take A Stand On Oil (11/4/14)
11/5/2014 5:54:00 AM - Seeking Alpha


First Week of June 2015 Options Trading For Acadia Pharmaceuticals (ACAD)
10/23/2014 11:19:18 AM - BNK Invest


3 Stocks I'll Buy if the Market Crashes
10/20/2014 12:01:02 PM - Motley Fool


Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


Cramer's Lightning Round - You Get Good News From Regeneron (10/16/14)
10/17/2014 6:08:00 AM - Seeking Alpha


This Is A Good Time To Buy Acadia Pharmaceuticals
10/3/2014 6:15:00 PM - Seeking Alpha


Acadia Still Offers Considerable Upside Potential
9/27/2014 9:17:00 AM - Seeking Alpha


Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14)
9/12/2014 5:47:00 AM - Seeking Alpha


ACADIA: FDA Grants Breakthrough Therapy Status To NUPLAZID
9/2/2014 9:21:00 AM - RTT News


ACADIA: FDA Provisionally Accepts Trade Name, NUPLAZID, For Pimavanserin
8/28/2014 9:10:00 AM - RTT News


Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha


Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release
7/23/2014 9:01:00 AM - Seeking Alpha


ACAD Makes Bullish Cross Above Critical Moving Average
7/1/2014 11:08:01 AM - BNK Invest


Friday's ETF Movers: FNX, XBI
6/27/2014 1:16:35 PM - BNK Invest


ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 11:41:00 AM - Seeking Alpha


ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 9:41:45 AM - SeekingAlpha


Acadia Remains On Track With Pimavanserin Program
5/7/2014 10:41:00 AM - Seeking Alpha


Backtesting A Value Strategy
4/20/2014 7:38:00 AM - Seeking Alpha


Acadia Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month
4/20/2014 7:00:00 AM - Seeking Alpha


From Lab Bench To Bedside: David Lowe Brings Common Sense To Neuroscience Investing
3/30/2014 7:38:00 AM - Seeking Alpha


3 Biotech Stocks Trading The Wrong Direction In March
3/28/2014 4:58:00 PM - Seeking Alpha